We are live on
!
Find out more
SAM
Sectoral Asset Management Portfolio holdings
AUM
$121M
1-Year Est. Return
73.47%
This Fund
S&P 500
This Quarter
Est. Return
+18.69%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$831M
AUM Growth
+$95.7M
(+13%)
Cap. Flow
-$18.2M
Cap. Flow
% of AUM
-2.19%
Top 10 Holdings %
Top 10 Hldgs %
37.16%
Holding
117
New
13
Increased
23
Reduced
36
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$28.2M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$16.5M |
| 3 |
Merck
MRK
|
+$12.9M |
| 4 |
AGN
Allergan plc
AGN
|
+$12.3M |
| 5 |
Assembly Biosciences
ASMB
|
+$11.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
+$26.1M |
| 2 |
FOLD
Amicus Therapeutics
FOLD
|
+$20.1M |
| 3 |
CELG
Celgene Corp
CELG
|
+$19M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
+$18.6M |
| 5 |
AERI
Aerie Pharmaceuticals
AERI
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 84.63% |
| 2 | Industrials | 2.17% |
| 3 | Technology | 1.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOLD
1
DELISTED
Amicus Therapeutics
FOLD
| $46.2M | 5.55% |
3,394,623
-1,641,967
| -33% | -$20.1M |
|
|
AERI
2
DELISTED
Aerie Pharmaceuticals
AERI
| $39.9M | 4.8% |
839,954
-294,000
| -26% | -$12.9M |
|
3
Alnylam Pharmaceuticals
ALNY
$36.4B
| $36.5M | 4.4% |
391,041
-104,300
| -21% | -$8.72M |
|
|
APLS
4
DELISTED
Apellis Pharmaceuticals
APLS
| $33.7M | 4.05% |
1,727,829
-440,286
| -20% | -$6.92M |
|
5
Teladoc Health
TDOC
$1.74B
| $32.9M | 3.96% |
591,481
-40,594
| -6% | -$2.48M |
|
|
SWAV
6
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $28.4M | 3.42% |
+849,811
| New | +$28.2M |
|
7
Gilead Sciences
GILD
$165B
| $28.4M | 3.41% |
436,140
+11,250
| +3% | +$748K |
|
|
ARRY
8
DELISTED
Array Biopharma Inc
ARRY
| $22.2M | 2.67% |
909,968
-1,255,799
| -58% | -$26.1M |
|
|
PTLA
9
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $21.1M | 2.54% |
609,357
-214,250
| -26% | -$6.18M |
|
10
Novartis
NVS
$285B
| $19.6M | 2.36% |
227,715
-10,491
| -4% | -$842K |
|
11
Pfizer
PFE
$141B
| $17.8M | 2.14% |
441,759
-6,535
| -1% | -$262K |
|
12
PTC Therapeutics
PTCT
$6.47B
| $17.4M | 2.1% |
463,137
+229,601
| +98% | +$7.71M |
|
|
CELG
13
DELISTED
Celgene Corp
CELG
| $17M | 2.04% |
179,700
-217,312
| -55% | -$19M |
|
|
HRC
14
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $16.8M | 2.02% |
158,799
-1,400
| -0.9% | -$141K |
|
|
WMGI
15
DELISTED
Wright Medical Group Inc
WMGI
| $15.8M | 1.9% |
501,272
-33,200
| -6% | -$1.01M |
|
|
RARX
16
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $15.4M | 1.85% |
686,513
-113,099
| -14% | -$2.43M |
|
|
17
Sarepta Therapeutics
SRPT
$1.78B
| $15.3M | 1.84% |
+128,098
| New | +$16.5M |
|
18
Evolent Health
EVH
$667M
| $15.2M | 1.82% |
1,204,402
+615,500
| +105% | +$9.74M |
|
|
GBT
19
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $14.5M | 1.74% |
273,341
-9,200
| -3% | -$452K |
|
20
Eli Lilly
LLY
$1.02T
| $14.5M | 1.74% |
111,465
+7,299
| +7% | +$888K |
|
21
Collegium Pharmaceutical
COLL
$1.15B
| $14.1M | 1.7% |
934,334
-222,600
| -19% | -$3.57M |
|
|
22
Assembly Biosciences
ASMB
$497M
| $14.1M | 1.7% |
59,650
+46,533
| +355% | +$11.8M |
|
|
23
Merck
MRK
$307B
| $13.7M | 1.65% |
+172,606
| New | +$12.9M |
|
|
XLRN
24
DELISTED
Acceleron Pharma
XLRN
| $12.5M | 1.51% |
269,396
+57,670
| +27% | +$2.53M |
|
|
AGN
25
DELISTED
Allergan plc
AGN
| $12.4M | 1.5% |
+84,900
| New | +$12.3M |
|
Similar funds
RIP
CCM
LFWA
FWA
CF
WIM
MW
AFC
Sectoral Asset Management's Q1 2019 Portfolio in Review
As of Q1 2019, Sectoral Asset Management held 117 positions worth $831M, up 13% from $736M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Sectoral Asset Management's Q1 2019 filing shows 13 new, 23 increased, 36 reduced and 11 closed positions. Its largest new stake was Shockwave Medical, Inc. Common Stock: 849,811 shares worth $28.4M. The largest sale was Array Biopharma Inc, an estimated $26.1M.
By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 82% a quarter earlier, followed by Industrials and Technology.
- Sectoral Asset Management's largest Q1 2019 buy was Shockwave Medical, Inc. Common Stock: 849,811 shares worth $28.4M.
- Sectoral Asset Management added most to Assembly Biosciences in Q1 2019, an estimated $11.8M increase.
- Sectoral Asset Management's biggest Q1 2019 reduction was Array Biopharma Inc, cutting an estimated $26.1M.
- Sectoral Asset Management fully exited Immunomedics Inc in Q1 2019, selling an estimated $18.6M.
- Sectoral Asset Management's ten largest holdings make up 37% of its $831M portfolio in Q1 2019.
- Sectoral Asset Management opened 13 new positions and closed 11 in Q1 2019.
- Sectoral Asset Management's portfolio value rose 13% quarter-over-quarter to $831M.
Based on Sectoral Asset Management's 13F filing for Q1 2019, filed 14 May 2019.